Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs

NCT00652288 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type I

Interventions

DRUG: Insulin analogs (Lispro and Aspart)
DRUG: Insulin analogs (Aspart and Detemir)
DRUG: Insulin analogs (Aspart and Detemir)
DRUG: Insulin analogs (Lispro and Glargine)
DRUG: Insulin analogs (Lispro and Glargine)

Sponsor

Yale University